Desktop Site
|
26 Apr 24 | 14:33
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,826.65
-512.79
-0.69 %
Corporate Announcement
Security Code
524804
Company
Aurobindo Pharma Ltd
Exchange Received Time
24/02/2020 10:44:44
Exchange Disseminated Time
24/02/2020 10:44:53
Time Taken
00:00:09
Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
2/24/2020 10:44:46 AM
Please refer to our letter dated February 3, 2020 wherein we have intimated the schedule of Investors/Analysts call on February 7, 2020. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2019 and the same is being uploaded on the website of the Company and is available in the following web link:
https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/
Attachment
<< Back
Recently Viewed